Clinical trial
Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes.
NCT00254085 · University Hospital, Gentofte, Copenhagen, Other · Unknown status
Key facts
| NCT number | NCT00254085 |
|---|---|
| Title | Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes. |
| Official title | Multiple Substitution of First Phase Insulin Response With a Rapid Action Insuli Analogue in Patient With Newly Diagnosed Type 2 Diabtes. |
| Lead sponsor | University Hospital, Gentofte, Copenhagen, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | Insulin Aspart |
| Enrollment | 20 |
| Start date | Mar 1, 2005 |
| Completion | Mar 1, 2006 |
| First posted | Nov 15, 2005 |
| Last update posted | Nov 15, 2005 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: